Skip to content
🌐 Global🇮🇳 India📍 Asia-Pacific📍 Bihar📍 Delhi-NCR📍 East India📍 Europe📍 Gujarat📍 Karnataka📍 Kerala📍 Madhya Pradesh📍 Maharashtra📍 Middle East📍 North India📍 Northeast India📍 Punjab📍 Rajasthan📍 South India📍 Tamil Nadu📍 Telangana📍 United Kingdom📍 United States📍 Uttar Pradesh📍 West Bengal📍 West India
LIVE
Home / Technology
Technology

Indegene Embarks on Indo‑UK Life‑Sciences Corridor with C‑CAMP

Bengaluru‑based biotech firm Indegene has joined the C‑CAMP, an Indo‑UK life‑sciences corridor that partners with Imperial College London. The collaboration aims to accelerate translational research and bring cutting‑edge therapies to market.

Times of India GujaratNovember 19, 20261 min read
Share this story
Indegene Embarks on Indo‑UK Life‑Sciences Corridor with C‑CAMP
The Strategic Consequence
Indegene’s entry into C‑CAMP will likely catalyze increased biotech collaboration, boosting India’s life‑science exports and attracting foreign investment over the next year.

Bengaluru‑based biotech firm Indegene has joined the C‑CAMP, an Indo‑UK life‑sciences corridor that partners with Imperial College London. The collaboration, announced in November, aims to accelerate translational research and bring cutting‑edge therapies to market. Indegene’s participation signals a growing trend of Indian firms seeking international partnerships to enhance R&D capabilities.

The partnership leverages C‑CAMP’s infrastructure, including state‑of‑the‑art laboratories and access to a network of academic and industry experts. By integrating Indegene’s expertise in genomic diagnostics with Imperial College’s research strengths, the alliance seeks to shorten the development cycle for novel therapeutics. The collaboration also provides a platform for talent exchange and joint funding opportunities.

Advertisement

The immediate consequence is the creation of joint research projects that could yield new diagnostic tools and treatment modalities. Over the next year, the partnership may attract additional investment from venture capital and public funding, positioning the corridor as a hub for life‑science innovation. In the long run, the collaboration could elevate India’s standing in the global biotech arena and spur domestic capacity building.

📰 Primary Source Publication Verified Resource & Provenance
✉
The Next Brief
Get the day's most important stories in one email
AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

Advertisement

Related stories

Most read

  1. 1Nepal PM Balendra Shah to cut short 1st India visit from 3 days to 25 hoursTop Stories
  2. 2California Insurers Must Reopen Policies After Dove Fire FalloutEnvironment
  3. 3‘Ramayana’ nears Rs 1,500 crore mark at worldwide box officeEntertainment
  4. 4Tech Glitches Disrupt United Airlines and Major U.S. BanksTechnology
  5. 5Boeing Unveils Revived 737‑200 ‘Phoenix’ at Kempegowda International AirportTechnology